Rheumatoid arthritis shows a heightened mortality risk linked to insulin resistance, with higher triglyceride-glucose indexes lowering survival rates.
Multivariate analysis indicates a 1.6-fold increase in all-cause mortality with higher TyG, and a 2.36-fold increase in cardiovascular mortality in RA participants.
Sensitivities support the relationship between biomarkers of insulin resistance and mortality risk, emphasizing chronic disease management for RA.
Effect modification by factors such as BMI, drinking, and race suggests a complex interaction in mortality risk factors among RA patients.